Economic Reporter :
Beximco Pharmaceuticals Limited (“BPL”, “Beximco Pharma” or “Company”) has commenced export of medicines to Kuwait, a press release says on Thursday.
This is the first time a Bangladeshi pharmaceutical company has launched pharmaceutical products in any gulf member country (GCC). A launching ceremony was held at the factory Photopremises of Beximco Pharma to mark the shipment of first consignment to Kuwait in presence of the ambassador of Kuwait His Excellency Mr. Adel Mohammad A. H Hayat. Vice Chairman of Beximco group Mr. Salman F Rahman, Beximco Pharma’s Managing Director Mr. Nazmul Hassan, MP, Chief operating Officer Rabbur Reza and other high officials of the company were also present on this occasion.
The ambassador has also seen the operations of various units at Tongi factory and expressed high satisfaction over the state-of-the-art facilities and quality control practices of Beximco Pharma. He expressed keen interest in Beximco medicines and hoped for substantial import from the company in the near future.
Initially two metered dose inhaler products for asthma and respiratory disorders namely Azmasol (Salbutamol) and Bexitrol-F (Salmeterol plus Fluticasone) and one blood pressure drug Amdocal (Amlodipine) are being exported to Kuwait. The Company expects to launch additional products in Kuwait later this year. Total pharma market of the Gulf Cooperation Council (GCC), consisting of six Arab nations, is currently valued at around $9 billion and Kuwait has a pharma market worth about a billion dollar.
Answering to the questions from journalists Salman F Rahman said “Beximco pharma is exporting medicine to 54 countries including Kuwait. Beximco Pharma had worked hard for the last seven years to get necessary approvals from the authority which are normally a lengthy process as well. Now we are expecting to export 1 billion dollar within next five years which was 15 million dollar las year.”
Beximco Pharmaceuticals Limited (“BPL”, “Beximco Pharma” or “Company”) has commenced export of medicines to Kuwait, a press release says on Thursday.
This is the first time a Bangladeshi pharmaceutical company has launched pharmaceutical products in any gulf member country (GCC). A launching ceremony was held at the factory Photopremises of Beximco Pharma to mark the shipment of first consignment to Kuwait in presence of the ambassador of Kuwait His Excellency Mr. Adel Mohammad A. H Hayat. Vice Chairman of Beximco group Mr. Salman F Rahman, Beximco Pharma’s Managing Director Mr. Nazmul Hassan, MP, Chief operating Officer Rabbur Reza and other high officials of the company were also present on this occasion.
The ambassador has also seen the operations of various units at Tongi factory and expressed high satisfaction over the state-of-the-art facilities and quality control practices of Beximco Pharma. He expressed keen interest in Beximco medicines and hoped for substantial import from the company in the near future.
Initially two metered dose inhaler products for asthma and respiratory disorders namely Azmasol (Salbutamol) and Bexitrol-F (Salmeterol plus Fluticasone) and one blood pressure drug Amdocal (Amlodipine) are being exported to Kuwait. The Company expects to launch additional products in Kuwait later this year. Total pharma market of the Gulf Cooperation Council (GCC), consisting of six Arab nations, is currently valued at around $9 billion and Kuwait has a pharma market worth about a billion dollar.
Answering to the questions from journalists Salman F Rahman said “Beximco pharma is exporting medicine to 54 countries including Kuwait. Beximco Pharma had worked hard for the last seven years to get necessary approvals from the authority which are normally a lengthy process as well. Now we are expecting to export 1 billion dollar within next five years which was 15 million dollar las year.”
